Customize Consent Preferences

We use cookies to help you navigate efficiently and perform certain functions. You will find detailed information about all cookies under each consent category below.

The cookies that are categorized as "Necessary" are stored on your browser as they are essential for enabling the basic functionalities of the site. ... 

Always Active

Necessary cookies are required to enable the basic features of this site, such as providing secure log-in or adjusting your consent preferences. These cookies do not store any personally identifiable data.

No cookies to display.

Functional cookies help perform certain functionalities like sharing the content of the website on social media platforms, collecting feedback, and other third-party features.

No cookies to display.

Analytical cookies are used to understand how visitors interact with the website. These cookies help provide information on metrics such as the number of visitors, bounce rate, traffic source, etc.

No cookies to display.

Performance cookies are used to understand and analyze the key performance indexes of the website which helps in delivering a better user experience for the visitors.

No cookies to display.

Advertisement cookies are used to provide visitors with customized advertisements based on the pages you visited previously and to analyze the effectiveness of the ad campaigns.

No cookies to display.

3.138.200.26
dgid:
enl:
npi:0
-Advertisement-
-Advertisement-
Journal Scan
Oncology

Potential driver for metastasis in bone cancer identified

Posted on

Researchers discovered a new multidimensional MAPK7/MMP9 signaling hub in primary bone cancer metastasis, according to a study in Oncogene.

Using whole tumor plus single-cell RNA-sequencing and circulating tumor cells, researchers discovered mitogen-activated protein kinase 7/matrix metallopeptidase 9 (MAPK7/MMP9) signaling, acting as a driver for primary bone cancer metastasis, including lung metastasis.   

-Advertisement-
-Advertisement-

Blocking this signaling pathway may suppress tumor burden and metastatic spread.

The approach here finds that blockade of MAPK7/MMP9 signalling may overcome current hurdles for targeting pathways that ultimately lead to metastatic lung nodule formation in a childhood cancer,” the authors concluded.

Reference

Green D, Eyre H, Singh A, et al. Targeting the MAPK7/MMP9 axis for metastasis in primary bone cancer. Oncogene. 2020;https://doi.org/10.1038/s41388-020-1379-0.

-Advertisement-
-Advertisement-
-Advertisement-
-Advertisement-